Cargando…
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
BACKGROUND: Osteopontin (OPN) is associated with human cancers, and circulating blood OPN may have diagnostic or prognostic value in clinical oncology. METHODS: To evaluate OPN as a cancer biomarker, we generated and characterized five novel mouse monoclonal antibodies against the human full-length...
Autores principales: | Plumer, Alicia, Duan, Hongyi, Subramaniam, Sripriya, Lucas, F Lee, Miesfeldt, Susan, Ng, Ah-Kau, Liaw, Lucy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259319/ https://www.ncbi.nlm.nih.gov/pubmed/18237408 http://dx.doi.org/10.1186/1471-2407-8-38 |
Ejemplares similares
-
Intrinsically Disordered Osteopontin Fragment Orders During Interfacial Calcium Oxalate Mineralization
por: Lu, Hao, et al.
Publicado: (2021) -
Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients
por: Leung, Danny T. M., et al.
Publicado: (2016) -
A targeted isotope dilution mass spectrometry assay for osteopontin quantification in plasma of metastatic breast cancer patients
por: Leslie, Andrew, et al.
Publicado: (2023) -
Lactoferrin quantification in cattle faeces by ELISA
por: Cooke, Andrew S., et al.
Publicado: (2020) -
Inactivation of the Osteopontin Gene Enhances Vascular Calcification of Matrix Gla Protein–deficient Mice: Evidence for Osteopontin as an Inducible Inhibitor of Vascular Calcification In Vivo
por: Speer, Mei Y., et al.
Publicado: (2002)